Oppenheimer Starts 89bio Inc. (ETNB) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
SVB Leerink Starts 89bio Inc. (ETNB) at Outperform
December 9, 2019 7:08 AM ESTSVB Leerink analyst Pasha Sarraf initiates coverage on 89bio Inc. (NASDAQ: ETNB) with a Outperform rating and a price target of $55.00.
For an analyst ratings summary and ratings history on 89bio Inc. click here. For more ratings news on 89bio Inc. click here.
Shares of 89bio Inc. closed at $28.60 yesterday.
... MoreUPDATE: RBC Capital Starts 89bio Inc. (ETNB) at Outperform
December 9, 2019 5:34 AM EST(Updated - December 9, 2019 6:42 AM EST)
(updated to add analyst comments)
RBC Capital analyst Brian Abrahams initiates coverage on 89bio Inc. (NASDAQ: ETNB) with a Outperform rating and a price target of $36.00 and a 'Speculative Risk' qualifier.
The... More
